Anove-logoAnove-logoExplAIn
KaartenAI-koplopers
Terug naar directory

Transpara

door ScreenPoint Medical

AI Application
Laag vertrouwen

Transpara is software for 2D mammograms and 3D digital breast tomosynthesis, used by breast radiologists in screening and diagnostic breast imaging. The vendor says the AI marks suspicious regions with a region risk score on a 98-point scale and puts each exam in an Elevated, Intermediate or Low risk category; Low risk exams are left unmarked. Further modules assess breast density and compare findings with up to three prior mammograms. The vendor says Transpara can be used as decision support while reading, as an independent second reader, or to organise the workflow, and that where double reading is practised users may use it as a partial replacement of the second reader or as a third reader. In each set-up the vendor describes, a radiologist still reads the exam. The vendor names PACS and AI-platform partners, but its website says nothing about where images are processed or hosted.

Bezoek website

Transparantiescore

Gewogen over vier pijlers · bijgewerkt October 20, 2026

Totaalscore
40% gewogen
ABCDF
Model
—
Nog niet beoordeeld
Infrastructuur
—
Nog niet beoordeeld

Functionaliteiten

Breast Cancer Detection
Exam Risk Categorisation
Lesion Marking
Breast Density Assessment
Prior Comparison

Leveranciersinformatie

Volledige informatie over de leverancier/provider van deze AI-applicatie

ScreenPoint MedicalBekijk alle producten →
ScreenPoint Medical B.V.(Handelsnaam: ScreenPoint Medical)
Contactinformatie
screenpoint-medical.com
info@screenpointmed.com
+31 242 020 020
Geregistreerd adres
Toernooiveld 300, Nijmegen, Gelderland, 6525 EC, NL

Leveranciersinformatie volgens de EU AI Act

Verificatiestatus:
Unverified
(Laatst geverifieerd: October 20, 2026)
ScreenPoint Medical B.V.(Handelsnaam: ScreenPoint Medical)
Toernooiveld 300, Nijmegen, Gelderland, 6525 EC, NL
info@screenpointmed.com+31 242 020 020
Nalevingsdocumenten
CE-markering: Certified
Aangemelde instantie: DEKRA Certification B.V.
ScreenPoint says 'Not all features are available in all countries' and describes CE-marked use as decision support, an independent second reader or a workflow tool, including as a (partial) replacement of the second reader or as a third reader where double reading is practised (https://screenpoint-medical.com/insights/transpara-regulatory-clearances, dated 22 Oct 2025, read 2026-10-20). Its website publishes no contraindications or instructions for use.
Naleving & risico

Krijg inzicht in risico's door beoordelingen uit te voeren op deze AI-applicatie.

Werk je bij ScreenPoint Medical? Claim deze vermelding om de gegevens te corrigeren of aan te vullen.

Toegevoegd: October 20, 2026
Bijgewerkt: October 20, 2026

Klaar om AI-applicaties te beheren?

Volg, beoordeel en beheer je AI-applicaties met Anove.

Anove-logoAnove-logoAnove International B.V.

We helpen organisaties AI-applicaties op een verantwoorde manier te ontdekken en beheren. Uw betrouwbare bron voor AI-governance en compliance.

Snelle links

  • Directory bekijken
  • FAQ
  • AI-kaarten per sector
  • Inloggen

Bronnen

  • Documentatie
  • Status
  • Anove.ai

Voorwaarden

  • Privacybeleid
  • Algemene voorwaarden
  • Responsible disclosure
  • AI-juridische kennisgeving
  • Beveiligingsbeleid

© 2026 Anove International B.V. Alle rechten voorbehouden.